Medication in the last days of life for motor neuron disease/amyotrophic lateral sclerosis.

@article{Oliver2010MedicationIT,
  title={Medication in the last days of life for motor neuron disease/amyotrophic lateral sclerosis.},
  author={David Oliver and Colin F Campbell and Tony O'brien and Richard Sloan and Nigel Sykes and Carol Tallon and Jane Taylor-Horan and Mayen Udoma},
  journal={Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases},
  year={2010},
  volume={11 6},
  pages={
          562-4
        }
}
Our objective was to study the use of opioid and other medication at the end of life for patients with ALS/MND under specialist palliative care. A retrospective study looked at the medication received by 62 patients with MND/ALS in the last 72 h of life in six hospices in the UK and Ireland. Medication is widely used in the last 24 h of life, and use of the parenteral route increases as death approaches. We found that the doses of opioids and other medication do not increase appreciably during… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-7 of 7 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 10 references

Palliative care in amyotrophic lateral sclerosis

Journal of Neurology • 1997
View 10 Excerpts
Highly Influenced

Palliative care

D. Oliver
Palliative Care in Amyotrophic Lateral Sclerosis – from diagnosis to bereavement • 2006

The death of Harold Shipman

A Hoy
Eur J Pall Care • 2004

The quality of care and symptom control: the 6. effects on the terminal phase of MND/ALS

D. Oliver
J Neuro Sci • 1996
View 1 Excerpt

hospice perspective

C Neudert, D Oliver, M Wasner, GD. Borasio
Br Med J. 1992;304:471 • 1992
View 1 Excerpt

motor neuron disease in a hospice

C Saunders, DH Sum- mers, N Teller, editors
1981